{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:46:34Z","timestamp":1787003194421,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K19462"],"award-info":[{"award-number":["22K19462"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51873-x","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:03:50Z","timestamp":1726495430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["IL36G-producing neutrophil-like monocytes promote cachexia in cancer"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1490-9923","authenticated-orcid":false,"given":"Yoshihiro","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushige","family":"Kamimura-Aoyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Noka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushin","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Matsunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3785-2317","authenticated-orcid":false,"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-3176","authenticated-orcid":false,"given":"Yuka","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-5470","authenticated-orcid":false,"given":"Hironori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"51873_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s, J. M., Busquets, S., Stemmler, B. & L\u00f3pez-Soriano, F. J. Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer 14, 754\u2013762 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"51873_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"51873_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"S von Haehling","year":"2010","unstructured":"von Haehling, S. & Anker, S. D. Cachexia as a major underestimated and unmet medical need: facts and numbers. J. Cachexia Sarcopenia Muscle 1, 1\u20135 (2010).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"51873_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211\u2013217 (2005).","journal-title":"Cancer Cell"},{"key":"51873_CR5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"51873_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni, D., Angell, H. K. & Galon, J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Reviews Cancer 20, 662\u2013680 (2020).","journal-title":"Nat. Reviews Cancer"},{"key":"51873_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"51873_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/JLB.3MR0717-292R","volume":"103","author":"MR Galdiero","year":"2018","unstructured":"Galdiero, M. R., Varricchi, G., Loffredo, S., Mantovani, A. & Marone, G. Roles of neutrophils in cancer growth and progression. J. Leukocyte Biol.103, 457\u2013464 (2018).","journal-title":"J. Leukocyte Biol."},{"key":"51873_CR9","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3389\/fimmu.2019.01690","volume":"10","author":"HH Oberg","year":"2019","unstructured":"Oberg, H. H., Wesch, D., Kalyan, S. & Kabelitz, D. Regulatory interactions between neutrophils, tumor cells and T cells. Front. Immunol. 10, 1690 (2019).","journal-title":"Front. Immunol."},{"key":"51873_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","volume":"580","author":"B Maier","year":"2020","unstructured":"Maier, B. et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature 580, 257\u2013262 (2020).","journal-title":"Nature"},{"key":"51873_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora, M. et al. TREM2 Modulation remodels the tumor myeloid landscape enhancing Anti-PD-1 immunotherapy. Cell 182, 886\u2013900.e817 (2020).","journal-title":"Cell"},{"key":"51873_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845 (2019).","journal-title":"Cell"},{"key":"51873_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334 (2019).","journal-title":"Immunity"},{"key":"51873_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"51873_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.aac9407","volume":"350","author":"RN Hanna","year":"2015","unstructured":"Hanna, R. N. et al. Patrolling monocytes control tumor metastasis to the lung. Science 350, 985\u2013990 (2015).","journal-title":"Science"},{"key":"51873_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta, L. et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell 35, 588\u2013602.e510 (2019).","journal-title":"Cancer Cell"},{"key":"51873_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","volume":"22","author":"H Baazim","year":"2022","unstructured":"Baazim, H., Antonio-Herrera, L. & Bergthaler, A. The interplay of immunology and cachexia in infection and cancer. Nat. Rev. Immunol. 22, 309\u2013321 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"51873_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"51873_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcsm.12251","volume":"9","author":"EE Talbert","year":"2018","unstructured":"Talbert, E. E. et al. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients. J. Cachexia Sarcopenia Muscle 9, 358\u2013368 (2018).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"51873_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cancers14040963","volume":"14","author":"M Petruzzelli","year":"2022","unstructured":"Petruzzelli, M. et al. Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia. Cancers 14, 963 (2022).","journal-title":"Cancers"},{"key":"51873_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22361-3","volume":"12","author":"B Olson","year":"2021","unstructured":"Olson, B. et al. Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. Nat. Commun. 12, 2057 (2021).","journal-title":"Nat. Commun."},{"key":"51873_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3324\/haematol.2013.088161","volume":"99","author":"T Tadmor","year":"2014","unstructured":"Tadmor, T. et al. Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era. Haematologica 99, 125\u2013130 (2014).","journal-title":"Haematologica"},{"key":"51873_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0877-9","volume":"18","author":"F Feng","year":"2018","unstructured":"Feng, F. et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. BMC Gastroenterol. 18, 148 (2018).","journal-title":"BMC Gastroenterol."},{"key":"51873_CR24","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford, D. E. et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis. Clin. Cancer Res. 19, 3404\u20133415 (2013).","journal-title":"Clin. Cancer Res."},{"key":"51873_CR25","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1245\/s10434-016-5354-5","volume":"23","author":"K Shigeta","year":"2016","unstructured":"Shigeta, K. et al. High absolute monocyte count predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy. Ann. Surg. Oncol. 23, 4115\u20134122 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"51873_CR26","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","volume":"125","author":"D Selimoglu-Buet","year":"2015","unstructured":"Selimoglu-Buet, D. et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood 125, 3618\u20133626 (2015).","journal-title":"Blood"},{"key":"51873_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajh.25684","volume":"95","author":"MM Patnaik","year":"2020","unstructured":"Patnaik, M. M. & Tefferi, A. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am. J. Hematol. 95, 97\u2013115 (2020).","journal-title":"Am. J. Hematol."},{"key":"51873_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1182\/bloodadvances.2018025007","volume":"3","author":"Y Hayashi","year":"2019","unstructured":"Hayashi, Y. et al. NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis. Blood Adv. 3, 1047\u20131060 (2019).","journal-title":"Blood Adv."},{"key":"51873_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature19348","volume":"537","author":"A Olsson","year":"2016","unstructured":"Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698\u2013702 (2016).","journal-title":"Nature"},{"key":"51873_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2017.10.021","volume":"47","author":"A Y\u00e1\u00f1ez","year":"2017","unstructured":"Y\u00e1\u00f1ez, A. et al. Granulocyte-monocyte progenitors and monocyte-dendritic cell progenitors independently produce functionally distinct monocytes. Immunity 47, 890\u2013902.e894 (2017).","journal-title":"Immunity"},{"key":"51873_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"51873_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park, B. S. et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191\u20131195 (2009).","journal-title":"Nature"},{"key":"51873_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang, G. et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat. Med. 24, 770\u2013781 (2018).","journal-title":"Nat. Med."},{"key":"51873_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433\u2013447 (2014).","journal-title":"Cell Metab."},{"key":"51873_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233\u2013238 (2011).","journal-title":"Science"},{"key":"51873_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40571-9","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. Nat. Commun. 14, 5179 (2023).","journal-title":"Nat. Commun."},{"key":"51873_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01645-7","volume":"8","author":"M Segatto","year":"2017","unstructured":"Segatto, M. et al. Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival. Nat. Commun. 8, 1707 (2017).","journal-title":"Nat. Commun."},{"key":"51873_CR38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","volume":"157","author":"K Takashima","year":"2009","unstructured":"Takashima, K. et al. Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250\u20131262 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"51873_CR39","doi-asserted-by":"publisher","first-page":"e20191820","DOI":"10.1084\/jem.20191820","volume":"217","author":"RY Ma","year":"2020","unstructured":"Ma, R. Y. et al. Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. J. Exp. Med. 217, e20191820 (2020).","journal-title":"J. Exp. Med."},{"key":"51873_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/gutjnl-2014-308988","volume":"65","author":"A Hamm","year":"2016","unstructured":"Hamm, A. et al. Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer. Gut 65, 990\u20131000 (2016).","journal-title":"Gut"},{"key":"51873_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2014.09.014","volume":"41","author":"M Chittezhath","year":"2014","unstructured":"Chittezhath, M. et al. Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. Immunity 41, 815\u2013829 (2014).","journal-title":"Immunity"},{"key":"51873_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","volume":"49","author":"M Guilliams","year":"2018","unstructured":"Guilliams, M., Mildner, A. & Yona, S. Developmental and functional heterogeneity of monocytes. Immunity 49, 595\u2013613 (2018).","journal-title":"Immunity"},{"key":"51873_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-38","volume":"7","author":"HW Chung","year":"2009","unstructured":"Chung, H. W. et al. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J. Transl. Med. 7, 38 (2009).","journal-title":"J. Transl. Med."},{"key":"51873_CR44","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"51873_CR45","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1038\/onc.2016.104","volume":"35","author":"C Hernandez","year":"2016","unstructured":"Hernandez, C., Huebener, P. & Schwabe, R. F. Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene 35, 5931\u20135941 (2016).","journal-title":"Oncogene"},{"key":"51873_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu, M. et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174\u2013179 (2006).","journal-title":"Shock"},{"key":"51873_CR47","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042\u20131049 (2007).","journal-title":"Nat. Med."},{"key":"51873_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fcell.2019.00317","volume":"7","author":"D Queen","year":"2019","unstructured":"Queen, D., Ediriweera, C. & Liu, L. Function and regulation of IL-36 signaling in inflammatory diseases and cancer development. Front. Dev. Biol. 7, 317 (2019).","journal-title":"Front. Dev. Biol."},{"key":"51873_CR49","doi-asserted-by":"publisher","first-page":"e144336","DOI":"10.1172\/JCI144336","volume":"131","author":"M Elias","year":"2021","unstructured":"Elias, M. et al. IL-36 in chronic inflammation and fibrosis - bridging the gap? J. Clin. Invest. 131, e144336 (2021).","journal-title":"J. Clin. Invest."},{"key":"51873_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11944-w","volume":"10","author":"E Giannoudaki","year":"2019","unstructured":"Giannoudaki, E. et al. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. Nat. Commun. 10, 4003 (2019).","journal-title":"Nat. Commun."},{"key":"51873_CR51","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"Chini CCS","year":"2020","unstructured":"Chini CCS et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels. Nat. Metab. 2, 1284\u20131304 (2020).","journal-title":"Nat. Metab."},{"key":"51873_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cmet.2016.07.005","volume":"24","author":"DW Frederick","year":"2016","unstructured":"Frederick, D. W. et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab. 24, 269\u2013282 (2016).","journal-title":"Cell Metab."},{"key":"51873_CR53","doi-asserted-by":"publisher","first-page":"361ra139","DOI":"10.1126\/scitranslmed.aaf5504","volume":"8","author":"D Ryu","year":"2016","unstructured":"Ryu, D. et al. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci. Transl. Med. 8, 361ra139 (2016).","journal-title":"Sci. Transl. Med."},{"key":"51873_CR54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","volume":"2","author":"AJ Covarrubias","year":"2020","unstructured":"Covarrubias, A. J. et al. Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages. Nat. Metab. 2, 1265\u20131283 (2020).","journal-title":"Nat. Metab."},{"key":"51873_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118 (2010).","journal-title":"Annu. Rev. Pathol."},{"key":"51873_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"51873_CR57","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","volume":"163","author":"F Paul","year":"2015","unstructured":"Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663\u20131677 (2015).","journal-title":"Cell"},{"key":"51873_CR58","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/2159-8290.CD-21-0032","volume":"12","author":"Y Aoyagi","year":"2022","unstructured":"Aoyagi, Y. et al. Mitochondrial fragmentation triggers ineffective hematopoiesis in myelodysplastic syndromes. Cancer Discov. 12, 250\u2013269 (2022).","journal-title":"Cancer Discov."},{"key":"51873_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-392","volume":"8","author":"J Chen","year":"2007","unstructured":"Chen, J., Xu, H., Aronow, B. J. & Jegga, A. G. Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinformatics 8, 392 (2007).","journal-title":"BMC Bioinformatics"},{"key":"51873_CR60","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51873-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:42:34Z","timestamp":1726728154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51873-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51873"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51873-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.H. reports consultancy for Novartis. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7662"}}